Rindert de Vries

848 citations

24 papers · 714 indexed · h-index 17

Co-authors: Robin P.F. Dullaart Wim J. Sluiter Robin P. F. Dullaart Arie van Tol Frank G. Perton Geesje M. Dallinga‐Thie Paul J.W.H. Kappelle Bruce H. R. Wolffenbuttel
Topics: Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers)Cardiovascular Health and Disease Prevention (8 papers)Adipokines, Inflammation, and Metabolic Diseases (7 papers)
Cited by: Endocrinology, Diabetes and Metabolism Clinical Biochemistry Cardiology and Cardiovascular Medicine
Journals: The Journal of Clinical Endocrinology & Metabolism Diabetes Clinica Chimica Acta
Partner nations: Netherlands Denmark Greece

In The Last Decade

Rindert de Vries

24 papers receiving 702 citations

Peers

Countries citing papers authored by Rindert de Vries

Since Specialization

Citations

This map shows the geographic impact of Rindert de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rindert de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rindert de Vries more than expected).

Fields of papers citing papers by Rindert de Vries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rindert de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rindert de Vries. The network helps show where Rindert de Vries may publish in the future.

Co-authorship network of co-authors of Rindert de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of Rindert de Vries. A scholar is included among the top collaborators of Rindert de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rindert de Vries. Rindert de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus 2014 ·Clinical Biochemistry ·Robin P.F. Dullaart,Rindert de Vries,Joop D. Lefrandt	15
2	Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus 2013 ·Atherosclerosis ·M. Triolo,Arjan J. Kwakernaak,Frank G. Perton,Rindert de Vries,Geesje M. Dallinga‐Thie,Robin P. F. Dullaart	18
3	Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A2 mass in type 2 diabetes mellitus: Relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity 2012 ·European Journal of Internal Medicine ·(unknown),Rindert de Vries,(unknown),Thomas Gautier,L. Joost van Pelt,Alexandros D. Tselepis,Laurent Lagrost,Robin P.F. Dullaart	11
4	Statin and Fibrate Combination Does not Additionally Lower Plasma Cholesteryl Ester Transfer in Type 2 Diabetes Mellitus 2012 ·Clinical Laboratory ·Rindert de Vries,Bert D. Dikkeschei,Wim J. Sluiter,Geesje M. Dallinga‐Thie,Arie van Tol,Robin P.F. Dullaart	7
5	Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects 2012 ·Clinica Chimica Acta ·Robin P.F. Dullaart,Paul J.W.H. Kappelle,Rindert de Vries	30
6	Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus 2011 ·Atherosclerosis ·Douwe J. Mulder,Jan Freark de Boer,Reindert Graaff,Rindert de Vries,Wijtske Annema,Joop D. Lefrandt,Andries J. Smit,Uwe J.F. Tietge,Robin P.F. Dullaart	21
7	Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects 2011 ·Atherosclerosis ·Rindert de Vries,Paul J.W.H. Kappelle,Geesje M. Dallinga‐Thie,Robin P. F. Dullaart	15
8	Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in non-diabetic subjects 2011 ·Clinica Chimica Acta ·Rindert de Vries,Frank G. Perton,Arie van Tol,Robin P. F. Dullaart	17
9	Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL 2011 ·European Journal of Clinical Investigation ·Paul J.W.H. Kappelle,Jan Freark de Boer,Frank G. Perton,Wijtske Annema,Rindert de Vries,Robin P.F. Dullaart,Uwe J.F. Tietge	54
10	Plasma Cholesteryl Ester Transfer, But Not Cholesterol Esterification, Is Related to Lipoprotein-Associated Phospholipase A2: Possible Contribution to an Atherogenic Lipoprotein Profile 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Robin P. F. Dullaart,(unknown),Frank G. Perton,(unknown),L. Joost van Pelt,Rindert de Vries,Arie van Tol	11
11	Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes 2011 ·European Journal of Clinical Investigation ·(unknown),L. Joost van Pelt,(unknown),Rindert de Vries,René A. Tio,Iwan C.C. van der Horst,Wim J. Sluiter,Robin P. F. Dullaart	16
12	Carotid artery intima media thickness associates with skin autofluoresence in non‐diabetic subjects without clinically manifest cardiovascular disease 2010 ·European Journal of Clinical Investigation ·Helen L. Lutgers,Reindert Graaff,Rindert de Vries,Andries J. Smit,Robin P.F. Dullaart	40
13	Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus 2010 ·Atherosclerosis ·Paul J.W.H. Kappelle,Josefin Ahnström,Bert D. Dikkeschei,Rindert de Vries,Wim J. Sluiter,Bruce H. R. Wolffenbuttel,Arie van Tol,Lars B. Nielsen,Björn Dahlbäck,Robin P. F. Dullaart	11
14	Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness 2009 ·Clinica Chimica Acta ·Robin P. F. Dullaart,Peter Plomgaard,Rindert de Vries,Björn Dahlbäck,Lars B. Nielsen	29
15	Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol 2008 ·European Journal of Endocrinology ·Robin P. F. Dullaart,Albert K. Groen,Geesje M. Dallinga‐Thie,Rindert de Vries,Wim J. Sluiter,Arie van Tol	29
16	High plasma C‐reactive protein (CRP) is related to low paraoxonase‐I (PON‐I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus 2008 ·Clinical Endocrinology ·Robin P.F. Dullaart,Rindert de Vries,Wim J. Sluiter,Hieronymus A.M. Voorbij	50
17	Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects 2007 ·Clinical Endocrinology ·Robin P. F. Dullaart,Rindert de Vries,(unknown),Anneke C. Muller Kobold,Wim J. Sluiter	63
18	Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender 2007 ·European Journal of Endocrinology ·Robin P.F. Dullaart,Rindert de Vries,Arie van Tol,Wim J. Sluiter	51
19	Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases 2007 ·Clinical Endocrinology ·Robin P.F. Dullaart,Rindert de Vries,Geesje M. Dallinga‐Thie,Wim J. Sluiter,Arie van Tol	19
20	Plasma Cholesteryl Ester Transfer Is a Determinant of Intima-Media Thickness in Type 2 Diabetic and Nondiabetic Subjects 2005 ·Diabetes ·Rindert de Vries,Frank G. Perton,Geesje M. Dallinga‐Thie,Arie M. van Roon,Bruce H. R. Wolffenbuttel,Arie van Tol,Robin P. F. Dullaart	68

About Rindert de Vries

Rindert de Vries is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Cardiology and Cardiovascular Medicine, having authored 24 papers that have together received 714 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Cardiovascular Health and Disease Prevention (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (391 citations), Clinical Biochemistry (122 citations) and Cardiology and Cardiovascular Medicine (161 citations). Rindert de Vries has collaborated with scholars based in Netherlands, Denmark and Greece. Frequent co-authors include Robin P.F. Dullaart, Wim J. Sluiter, Robin P. F. Dullaart, Arie van Tol, Frank G. Perton, Geesje M. Dallinga‐Thie, Paul J.W.H. Kappelle, Bruce H. R. Wolffenbuttel, Hieronymus A.M. Voorbij and Anneke C. Muller Kobold. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Clinica Chimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact